Last reviewed · How we verify
NCT06139432: CATATOES
Catatonia: Effectiveness of Transcranial Direct Current Electrostimulation (CATATOES)
NA trial testing Active tDCS in Catatonia in 70 participants. Status unknown.
31 December 2025
Quick facts
| Lead sponsor | Centre Hospitalier St Anne |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 December 2023 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Active tDCS
- Sham tDCS
Conditions studied
- Catatonia — all drugs for Catatonia →
Sponsor
Centre Hospitalier St Anne
Who can join
18 and older, any sex, with Catatonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Nearly 10% of people hospitalized in psychiatry have a catatonic syndrome. The treatment of this syndrome is based on lorazepam and electro-convulsive therapy (ECT) in drug-resistant forms. ECT is the reference therapy, very effective in catatonia, but remain difficult to access due to the technical platform required for their realization, leading to delays in the implementation of the treatment responsible for an increase in the morbidity and mortality of catatonia. In this context, a new therapeutic tool available in the treatment of drug-resistant catatonia would improve the prognosis of catatonia. Transcranial direct current stimulation (tDCS) is an alternative, non-invasive brain stimulation technique that does not require anesthesia, and inexpensive and has been shown to be effective in depression and schizophrenia. A series of clinical cases suggests its potential efficacy in catatonia. Our objective is to evaluate the efficacy of tDCS in catatonia in a clinical trial.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Moving to accelerated protocols of tDCS in catatonia: a case report.
Bouaziz N, Luisada JC, Jabri S, Andrianisaina PS, et al · · 2023 · cited 6× · PMID 38188043 · DOI 10.3389/fpsyt.2023.1302718 -
CATATOnia treatment with transcranial direct current electrostimulation: protocol of a randomised, double-blind, placebo-controlled bicentric superiority study (CATATOES).
Moyal M, Attali D, Berre AL, Bouaziz N, et al · · 2025 · PMID 41062970 · DOI 10.1186/s12888-025-07266-5 -
CATATOnia treatment with transcranial direct current ElectroStimulation: protocol of a randomised, double-blind, placebo-controlled bicentric superiority study (CATATOES)
Moyal M, Attali D, Berre AL, Bouaziz N, et al · · 2024 · DOI 10.21203/rs.3.rs-5355181/v1
Verify or expand the search:
- PubMed search for NCT06139432
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Active tDCS
Trials testing the same drug.
- NCT07246993 — Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms · NA · recruiting
- NCT07404319 — Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant · NA · not yet recruiting
- NCT07212829 — The Added Value of Transcranial Direct Current Stimulation (tDCS) During Exercise for People With Chronic Widespread Pai · NA · not yet recruiting
- NCT07202455 — Effect of Early Neuromodulation Coupled With Rehabilitation on the Prevention of Post-stroke Pain · NA · not yet recruiting
- NCT06901687 — Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS) · Phase 2 · recruiting
Other recruiting trials for Catatonia
Currently open trials in the same condition.
- NCT07315386 — Catatonic Syndrome in Adult Patients at Basurto Hospital: A Descriptive Study of Incidence, Comorbidity, and Short-Term · recruiting
- NCT04828226 — Clonidine to Prevent Delirium After Electroconvulsive Therapy. · Phase 4 · recruiting
Other Centre Hospitalier St Anne trials
Trials by the same sponsor.
- NCT07340736 — Sensory Mechanisms of Manual Dexterity Recovery After Stroke: a Prospective Cohort Study of Prediction and Cerebral Corr · NA · not yet recruiting
- NCT07376473 — Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningiomas · not yet recruiting
- NCT07395323 — Impact of Relaxation Sessions Using a Virtual Reality Application on the Sleep Quality of Caregivers Working Night Shift · NA · not yet recruiting
- NCT07283458 — Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS) · NA · not yet recruiting
- NCT07144956 — Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06139432 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier St Anne
- Last refreshed: 24 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06139432.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing